BioWorld Science

Dec. 15, 1998

View Archived Issues

Inex: Q3 1998 highlights

Read More

Sanofi-Synthelabo: poised to become number six in Europe

Read More

Next-generation SERM presented by Hoechst Marion Roussel

Read More

MAA for AcuTect temporarily withdrawn pending submission of additional information

Read More

AVI BioPharma reports encouraging clinical data from phase II Avicine study

Read More

Procept, Pacific Pharmaceuticals move closer to merger

Read More

Medarex reports setback in phase III trial of MDX-RA

Read More

Oxigene describes mechanism of action, therapeutic potential of declopramide

Read More

U.S. patent issues to Alexion, paving the way to improved xenotransplantation technology

Read More

Vanguard Medica takes on development of imiquimod analogue

Read More

First launch for Novartis anticoagulant takes place in Germany

Read More

Merckle launches new treatment for narcolepsy in Germany

Read More

Another market introduction for imiquimod

Read More

Anticoagulant cyclic diaza compounds reported by Cor Therapeutics

Read More

New antitumor compounds presented by Kyorin

Read More

Another merger agreement revealed: Corixa to acquire Anergen

Read More

New hemophilia treatment one step closer to market

Read More

New prostanoid compound from Ono is a useful tool for studying cardiovascular system

Read More

Novel glutamate receptor antagonist shows excellent potential as antiepileptic agent

Read More

Review of AIDSVAX studies past and present

Read More

Bayer and AxyS initiate development of oral asthma compound

Read More

Antipruritic, immunosuppressive MS-444 derivatives reported by Kyowa Hakko

Read More

Clinical studies support excellent safety and efficacy of Busulfex

Read More